FGEN : Insider Transactions for Fibrogen Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Fibrogen Inc (FGEN)

$1.10

0.09 (7.56%) as of 4:30 Fri 6/7

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

91,010,000

Market Cap:

100.11(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.3801 - $17.78

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : 6.8

Insider 3/6 Months : 7.4

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile FibroGen is a biopharmaceutical company that developes and commercializes a pipeline of therapeutics. Co. applies its capability in hypoxia-inducible factor (HIF) biology and connective tissue growth factor (CTGF) biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, Co.'s main product, is an inhibitor of HIF-prolyl hydroxylase activity that acts by stimulating the body's natural pathway of erythropoiesis or red blood cell production. Pamrevlumab is Co.'s human monoclonal antibody that inhibits the activity of CTGF for the treatment of idiopathic pulmonary fibrosis, locally advanced unresectable pancreatic cancer, and Duchenne muscular dystroph.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	50,000	50,000	50,000
Total Buy Value	$0	$95,470	$95,470	$95,470
Total People Bought	0	1	1	1
Total Buy Transactions	0	1	1	1
Total Shares Sold	0	0	46,257	259,386
Total Sell Value	$0	$0	$675,801	$4,794,856
Total People Sold	0	0	8	12
Total Sell Transactions	0	0	11	48
End Date	2024-03-10	2023-12-08	2023-06-09	2022-06-09

Adjust Filter Settings

Records found: 1243

Page 24 of 50

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Executive Officer

• • –

2018-07-19

4

AS

$64.27

$59,000

I/I

(918)

103,974

-

Chief Executive Officer

• • –

2018-07-19

4

AS

$64.34

$1,216,072

D/D

(18,900)

2,794,553

-

Chief Executive Officer

• • –

2018-07-19

4

OE

$3.60

$37,152

D/D

10,320

2,813,453

-

Rosenkranz Roberto Pedro

Director

– • –

2018-07-19

4

AS

$64.90

$64,900

D/D

(1,000)

32,700

-

Rosenkranz Roberto Pedro

Director

– • –

2018-07-19

4

OE

$9.78

$9,775

D/D

1,000

33,700

-

Chief Executive Officer

• • –

2018-07-18

4

AS

$65.48

$60,111

I/I

(918)

104,892

-

Chief Executive Officer

• • –

2018-07-18

4

AS

$65.19

$1,237,599

D/D

(18,900)

2,803,133

-

Chief Executive Officer

• • –

2018-07-18

4

OE

$3.60

$37,152

D/D

10,320

2,822,033

-

Director

– • –

2018-07-09

4

AS

$67.71

$406,260

D/D

(6,000)

131,540

-

Director

– • –

2018-07-09

4

OE

$18.00

$108,000

D/D

6,000

137,540

-

Chief Executive Officer

• • –

2018-07-06

4

AS

$65.61

$60,608

I/I

(918)

105,810

-

Chief Executive Officer

• • –

2018-07-06

4

AS

$64.15

$1,243,853

D/D

(18,900)

2,811,713

-

Chief Executive Officer

• • –

2018-07-06

4

OE

$3.60

$37,152

D/D

10,320

2,830,613

-

Chief Executive Officer

• • –

2018-07-05

4

AS

$63.92

$58,762

I/I

(918)

106,728

-

Chief Executive Officer

• • –

2018-07-05

4

AS

$63.97

$1,212,543

D/D

(18,900)

2,820,293

-

Chief Executive Officer

• • –

2018-07-05

4

OE

$3.60

$37,152

D/D

10,320

2,839,193

-

Chief Medical Officer

• – –

2018-07-03

4

AS

$65.00

$1,016,925

D/D

(15,645)

147,469

-

Chief Medical Officer

• – –

2018-07-03

4

OE

$14.58

$228,026

D/D

15,645

163,114

-

Schoeneck James A

Director

– • –

2018-07-03

4

AS

$65.00

$496,535

D/D

(7,639)

3,700

-

Schoeneck James A

Director

– • –

2018-07-03

4

OE

$2.90

$22,153

D/D

7,639

11,339

-

Schoeneck James A

Director

– • –

2018-06-22

4

AS

$65.00

$283,465

D/D

(4,361)

3,700

-

Schoeneck James A

Director

– • –

2018-06-22

4

OE

$2.90

$12,647

D/D

4,361

8,061

-

Rosenkranz Roberto Pedro

Director

– • –

2018-06-21

4

AS

$63.65

$63,650

D/D

(1,000)

32,700

-

Rosenkranz Roberto Pedro

Director

– • –

2018-06-21

4

OE

$9.78

$9,775

D/D

1,000

33,700

-

Chief Executive Officer

• • –

2018-06-21

4

AS

$63.60

$58,385

I/I

(918)

107,646

-

1243 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 24 of 50

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.